INS and polycystic ovary syndrome: It reduces lipogenesis, increases lipolysis [33,34] and decreases glucose and insulin levels, improving insulin sensitivity and glycemic control in patients with type 2 diabetes mellitus and gonadal function in women with PCOS [5,35,36,37].